Bubba Watson announced that he is partnering with a cannabidiol-product company cbdMD The multi-year deal with cbdMD will begin with the two-time major champion displaying the company’s logo on both sides of his head wear at the PGA Championship. You can see the video and full article here.

Watson will be the most high-profile professional player to endorse or invest in a cannabidiol (CBD)-related company. Scott McCarron, earlier this year, signed an endorsement deal with a hemp manufacturing company.

CBD is a property extracted from cannabis or marijuana plants and is said to reduce anxiety, inflammation, sleeplessness and chronic pain. In its pure form, it does not contain THC, the psychoactive component of cannabis, which makes it legal by PGA Tour standards.

“I’ve personally felt the benefits of cbdMD’s products,” said Watson in a statement. “cbdMD is the safest on the market and I am proud to partner with them to help millions feel better.”

The company claims its products are 100 percent organic with no traces of THC. They use a process that removes the leftover .3% of THC that full spectrum cbd oil has and creates broad spectrum CBD products.

Visit www.cbdmd.com and use CBDreview15 for 15% off your purchase now and in the future

What is CBD?

CBD stands for Cannabidiol, a Cannabinoid. Cannabidiol is derived from cannabis plant (also known as marijuana); however, it is not the same as the psychoactive derivative we know as the chemical compound THC (Tetrahydrocannabinol). CBD is NOT a psychoactive drug; it will not get you high.

In human clinical trials, CBD has long been studied for its potential application in various medical fields. It’s been shown that CBD has the ability to relieve inflammation, relieve pain, reduce seizures, reduce symptoms of psychosis, reduce muscle spasms, and reduce anxiety.  CBD is also being studied for applications in treating cancer.